Citations (72)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Estela Pineda, Marta Domenech, Ainhoa Hernández, Silvia Comas & Carmen Balaña. (2023) Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects. OncoTargets and Therapy 16, pages 71-86.
Read now
Read now
Xiaobu Ye, Karisa C. Schreck, Byram H. Ozer & Stuart A. Grossman. (2022) High-grade glioma therapy: adding flexibility in trial design to improve patient outcomes. Expert Review of Anticancer Therapy 22:3, pages 275-287.
Read now
Read now
Zheng Jin, Lianhua Piao, Guangchao Sun, Chuanxiang Lv, Yi Jing & Rihua Jin. (2021) Dual functional nanoparticles efficiently across the blood–brain barrier to combat glioblastoma via simultaneously inhibit the PI3K pathway and NKG2A axis. Journal of Drug Targeting 29:3, pages 323-335.
Read now
Read now
Nassima Leulmi, Denise Sighel, Andrea Defant, Karima Khenaka, Abderrahmane Boulahrouf & Ines Mancini. (2019) Nigericin and grisorixin methyl ester from the Algerian soil-living Streptomyces youssoufiensis SF10 strain: a computational study on their epimeric structures and evaluation of glioblastoma stem cells growth inhibition. Natural Product Research 33:2, pages 266-273.
Read now
Read now
Da Wang, Chao Wang, Liang Wang & Yue Chen. (2019) A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment. Drug Delivery 26:1, pages 551-565.
Read now
Read now
Shunping Han, Hongyue Zheng, Yanping Lu, Yue Sun, Anhao Huang, Weidong Fei, Xiaowei Shi, Xiuling Xu, Jingjing Li & Fanzhu Li. (2018) A novel synergetic targeting strategy for glioma therapy employing borneol combination with angiopep-2-modified, DOX-loaded PAMAM dendrimer. Journal of Drug Targeting 26:1, pages 86-94.
Read now
Read now
Articles from other publishers (66)
Ethan Chen, Alexander L Ling, David A Reardon & E Antonio Chiocca. (2023) Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling?. Neuro-Oncology.
Crossref
Crossref
Rupert Bartsch, Katarzyna J. Jerzak, Louis Larrouquere, Volkmar Müller & Emilie Le Rhun. (2023) Pharmacotherapy for leptomeningeal disease in breast cancer. Cancer Treatment Reviews, pages 102653.
Crossref
Crossref
Jack M. Shireman, Lingxin Cheng, Amiti Goel, Diogo Moniz Garcia, Sanil Partha, Alfredo Quiñones-Hinojosa, Christina Kendziorski & Mahua Dey. (2023) Spatial transcriptomics in glioblastoma: is knowing the right zip code the key to the next therapeutic breakthrough?. Frontiers in Oncology 13.
Crossref
Crossref
Heping Zhu, Xiaomin Song, Yihui Pan, Ming Li, Liang Chen, Pan Xiao, Rong Du, Ze Dong & Cai-Guang Yang. (2023) Design, synthesis, and biological evaluation of novel spirocyclic compounds as potential anti-glioblastoma agents. European Journal of Medicinal Chemistry 258, pages 115595.
Crossref
Crossref
Lilianne Beola, Nerea Iturrioz-Rodríguez, Carlotta Pucci, Rosalia Bertorelli & Gianni Ciofani. (2023) Drug-Loaded Lipid Magnetic Nanoparticles for Combined Local Hyperthermia and Chemotherapy against Glioblastoma Multiforme. ACS Nano.
Crossref
Crossref
Liron L. Israel, Tao Sun, Oliver Braubach, Alysia Cox, Ekaterina S. Shatalova, Harun-Mohammad Rashid, Anna Galstyan, Zachary Grodzinski, Xue Ying Song, Oksana Chepurna, Vladimir A. Ljubimov, Antonella Chiechi, Sachin Sharma, Connor Phebus, Yizhou Wang, Julia Y. Ljubimova, Keith L. Black & Eggehard Holler. (2023) β-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer's disease mouse models. Journal of Controlled Release 361, pages 636-658.
Crossref
Crossref
Monika Witusik-Perkowska, Pola Głowacka, Adam M. Pieczonka, Ewa Świderska, Agnieszka Pudlarz, Michał Rachwalski, Julia Szymańska, Magdalena Zakrzewska, Dariusz J. Jaskólski & Janusz Szemraj. (2023) Autophagy Inhibition with Chloroquine Increased Pro-Apoptotic Potential of New Aziridine-Hydrazide Hydrazone Derivatives against Glioblastoma Cells. Cells 12:14, pages 1906.
Crossref
Crossref
Temitayo Ayantayo, Marwa S A Emhemed, Asadur R Nabin, Roméo B Murhega, Mazin M Eltingary, Ahmed Naeem, Nathan Mugenyi, Jonas L Ibekwe, Lordstrong Akano, Mubarak J Mustapha, Bhavya R Maroo, Gobti B Abongha, Mèhomè W Dossou, Nicaise K Agada, Nourou D A Bankole & Victor M Kyaruzi. (2023) The safety and utility of low-intensity pulsed ultrasound for effective blood–brain barrier penetration in the treatment of glioblastoma: a scoping review protocol. Journal of Surgical Protocols and Research Methodologies 2023:3.
Crossref
Crossref
Christopher T. Moody, Phillip G. Durham, Paul A. Dayton & Yevgeny Brudno. (2023) Loading Intracranial Drug-Eluting Reservoirs Across the Blood–Brain Barrier With Focused Ultrasound. Ultrasound in Medicine & Biology 49:7, pages 1679-1685.
Crossref
Crossref
Josefine Graef, Stephanie Bluemel, Winfried Brenner, Holger Amthauer, Peter Truckenmueller, David Kaul, Peter Vajkoczy, Julia S. Onken & Christian Furth. (2023)
[
177
Lu]Lu-PSMA Therapy as an Individual Treatment Approach for Patients with High-Grade Glioma: Dosimetry Results and Critical Statement
. Journal of Nuclear Medicine 64:6, pages 892-895.
Crossref
Crossref
M.H. Ahmed, M. Canney, A. Carpentier & A. Idbaih. (2023) Overcoming the blood brain barrier in glioblastoma: Status and future perspective. Revue Neurologique 179:5, pages 430-436.
Crossref
Crossref
L. Brisson, L. Henrique Geraldo, A. Bikfalvi & T. Mathivet. (2023) The strange Microenvironment of Glioblastoma. Revue Neurologique 179:5, pages 490-501.
Crossref
Crossref
Aideen C. Roddy, Caitríona E. McInerney, Tom Flannery, Estelle G. Healy, James P. Stewart, Veronica J. Spence, Jamie Walsh, Manuel Salto-Tellez, Darragh G. McArt & Kevin M. Prise. (2023) Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification. Biomedicines 11:4, pages 1219.
Crossref
Crossref
Mohammed H. Ahmed, Isaias Hernández-Verdin, Emie Quissac, Nolwenn Lemaire, Coralie Guerin, Lea Guyonnet, Noël Zahr, Laura Mouton, Mathieu Santin, Alexandra Petiet, Charlotte Schmitt, Guillaume Bouchoux, Michael Canney, Marc Sanson, Maïté Verreault, Alexandre Carpentier & Ahmed Idbaih. (2023) Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model. Pharmaceutics 15:2, pages 455.
Crossref
Crossref
Andreas Bikfalvi, Cristine Alves da Costa, Tony Avril, Jean-Vianney Barnier, Luc Bauchet, Lucie Brisson, Pierre Francois Cartron, Hélène Castel, Eric Chevet, Hervé Chneiweiss, Anne Clavreul, Bruno Constantin, Valérie Coronas, Thomas Daubon, Monique Dontenwill, Francois Ducray, Natacha Entz-Werlé, Dominique Figarella-Branger, Isabelle Fournier, Jean-Sébastien Frenel, Mathieu Gabut, Thierry Galli, Julie Gavard, Gilles Huberfeld, Jean-Philippe Hugnot, Ahmed Idbaih, Marie-Pierre Junier, Thomas Mathivet, Philippe Menei, David Meyronet, Céline Mirjolet, Fabrice Morin, Jean Mosser, Elisabeth Cohen-Jonathan Moyal, Véronique Rousseau, Michel Salzet, Marc Sanson, Giorgio Seano, Emeline Tabouret, Aurélie Tchoghandjian, Laurent Turchi, Francois M. Vallette, Somya Vats, Maité Verreault & Thierry Virolle. (2023) Challenges in glioblastoma research: focus on the tumor microenvironment. Trends in Cancer 9:1, pages 9-27.
Crossref
Crossref
Vitor J. Cavalheiro, Ana Carolina P. Campos, Luiz G.C.A. Lima, Cairo Thomé Roça, Marcos Fernando L. Docema, Carmen Lucia P. Lancellotti, Raquel C.R. Martinez, Rosana L. Pagano, Roger Chammas, Manoel J. Teixeira, Marcos V.C. Maldaun & Iuri S. Neville. (2023) Unraveling the peripheral and local role of inflammatory cytokines in glioblastoma survival. Cytokine 161, pages 156059.
Crossref
Crossref
Laurent-Olivier Roy, Myriam Lemelin, Marie Blanchette, Marie-Belle Poirier, Salman Aldakhil & David Fortin. (2022) Expression of ABCB1, ABCC1 and 3 and ABCG2 in glioblastoma and their relevance in relation to clinical survival surrogates. Journal of Neuro-Oncology 160:3, pages 601-609.
Crossref
Crossref
Pankti Ganatra, Karen Saiswani, Nikita Nair, Avinash Gunjal, Ratnesh Jain & Prajakta Dandekar. 2022. Targeted Drug Delivery. Targeted Drug Delivery
299
326
.
Reena Jatyan, Prabhjeet Singh, Deepak Kumar Sahel, Y.G. Karthik, Anupama Mittal & Deepak Chitkara. (2022) Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme. Journal of Controlled Release 350, pages 494-513.
Crossref
Crossref
Dhivya Venkatesan, Ajay Elangovan, Harysh Winster, Md Younus Pasha, Kripa Susan Abraham, Satheeshkumar J, Sivaprakash P, Ayyadurai Niraikulam, Abilash Valsala Gopalakrishnan, Arul Narayanasamy & Balachandar Vellingiri. (2022) Diagnostic and therapeutic approach of artificial intelligence in neuro-oncological diseases. Biosensors and Bioelectronics: X 11, pages 100188.
Crossref
Crossref
Nikhil Pandey, Pavlos Anastasiadis, Christine P. Carney, Pranjali P. Kanvinde, Graeme F. Woodworth, Jeffrey A. Winkles & Anthony J. Kim. (2022) Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment. Advanced Drug Delivery Reviews 188, pages 114415.
Crossref
Crossref
Makoto Hirasawa, Mohammed A. A. Saleh & Elizabeth C. M. de Lange. (2022) The Extension of the LeiCNS-PK3.0 Model in Combination with the “Handshake” Approach to Understand Brain Tumor Pathophysiology. Pharmaceutical Research 39:7, pages 1343-1361.
Crossref
Crossref
Marcela Márquez, Karl Holmberg Olausson, Ayodele Alaiya, Sten Nilsson, Lennart Meurling & Anders R. Holmberg. (2022) Poly-guanidine shows high cytotoxicity in glioma cell cultures and glioma stem cells. Investigational New Drugs 40:3, pages 565-575.
Crossref
Crossref
Brandon Wee Siang Phon, Muhamad N.A. Kamarudin, Saatheeyavaane Bhuvanendran & Ammu K. Radhakrishnan. (2022) Transitioning pre-clinical glioblastoma models to clinical settings with biomarkers identified in 3D cell-based models: A systematic scoping review. Biomedicine & Pharmacotherapy 145, pages 112396.
Crossref
Crossref
Shirleen Miriam Marques & Lalit Kumar. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors
367
399
.
Ahmet Kaynak, Harold W. Davis, Subrahmanya D. Vallabhapurapu, Koon Y. Pak, Brian D. Gray & Xiaoyang Qi. (2021) SapC–DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents. Pharmaceuticals 14:11, pages 1193.
Crossref
Crossref
Ling He, Kruttika Bhat, Angeliki Ioannidis, Le Zhang, Nhan T. Nguyen, Joshua E. Allen, Phioanh Leia Nghiemphu, Timothy F. Cloughesy, Linda M. Liau, Harley I. Kornblum & Frank Pajonk. (2021) Effects of the DRD2/3 antagonist ONC201 and radiation in glioblastoma. Radiotherapy and Oncology 161, pages 140-147.
Crossref
Crossref
Mateusz Maszczyk, Zuzanna Rzepka, Jakub Rok, Artur Beberok & Dorota Wrześniok. (2021) Neobavaisoflavone May Modulate the Activity of Topoisomerase Inhibitors towards U-87 MG Cells: An In Vitro Study. Molecules 26:15, pages 4516.
Crossref
Crossref
Junsheng Li, Wen Wang, Jia Wang, Yong Cao, Shuo Wang & Jizong Zhao. (2021) Viral Gene Therapy for Glioblastoma Multiforme: A Promising Hope for the Current Dilemma. Frontiers in Oncology 11.
Crossref
Crossref
Jaewan Jeon, Sungmin Lee, Hyunwoo Kim, Hyunkoo Kang, HyeSook Youn, Sunmi Jo, BuHyun Youn & Hae Yu Kim. (2021) Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas. International Journal of Molecular Sciences 22:10, pages 5111.
Crossref
Crossref
Katherine E. Kunigelis & Michael A. Vogelbaum. (2021) Therapeutic Delivery to Central Nervous System. Neurosurgery Clinics of North America 32:2, pages 291-303.
Crossref
Crossref
Li Lihuang, Guo Qiuyan, Liu Yanxiu, Lu Mindan, Yang Jun, Ge Yunlong, Zhang Qiang, Sun Benqiang, Wang Xiumin, Li Liang-cheng & Ren Lei. (2021) Targeted combination therapy for glioblastoma by co-delivery of doxorubicin, YAP-siRNA and gold nanorods. Journal of Materials Science & Technology 63, pages 81-90.
Crossref
Crossref
Jianheng Wu, Linfan Li, Guangyuan Jiang, Hui Zhan, Xiumei Zhu & Wujun Yang. (2020) NCAPG2 facilitates glioblastoma cells’ malignancy and xenograft tumor growth via HBO1 activation by phosphorylation. Cell and Tissue Research 383:2, pages 693-706.
Crossref
Crossref
Jen-Fu Hsu, Shih-Ming Chu, Chen-Chu Liao, Chao-Jan Wang, Yi-Shan Wang, Mei-Yin Lai, Hsiao-Chin Wang, Hsuan-Rong Huang & Ming-Horng Tsai. (2021) Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update. Cancers 13:2, pages 195.
Crossref
Crossref
Jing Zhou, Xuejing Shi, Yaocheng Li, Shulan Hao, Zhi Guo, Fupeng Zhang, Yu Gao, Hao Guo & Likun Liu. (2021) Case report of pulmonary metastasis in a male Wistar rat glioblastoma model. Journal of Toxicologic Pathology 34:1, pages 95-99.
Crossref
Crossref
Mona Kamal Saadeldin, Amal Kamal Abdel-Aziz & Ahmed Abdellatif. (2021) Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis. Medical Hypotheses 146, pages 110365.
Crossref
Crossref
Mohammed Ahmed, Maite Verreault, Xavier Declèves & Ahmed Idbaih. 2021. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies
243
261
.
Huilong Luo & Eric V. Shusta. (2020) Blood–Brain Barrier Modulation to Improve Glioma Drug Delivery. Pharmaceutics 12:11, pages 1085.
Crossref
Crossref
Fulvio Borella, Luca Bertero, Antonio Morrone, Alessandro Gambella, Marialuisa Bovetti, Stefano Cosma, Andrea Carosso, Dionyssios Katsaros, Silvia Gemmiti, Mario Preti, Giorgio Valabrega, Giulia Scotto, Paola Cassoni & Chiara Benedetto. (2020) Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis. Cancers 12:8, pages 2156.
Crossref
Crossref
Jun Yang, Qiang Zhang, Yanxiu Liu, Xinjie Zhang, Wenjun Shan, Shefang Ye, Xi Zhou, Yunlong Ge, Xiumin Wang & Lei Ren. (2020) Nanoparticle-based co-delivery of siRNA and paclitaxel for dual-targeting of glioblastoma. Nanomedicine 15:14, pages 1391-1409.
Crossref
Crossref
Xuhui Wang, Sheng Yin, Man Li, Jingdong Rao, Dandan Wan, Yue Qiu, Qianwen Yu, Xiaoxiao Chen, Zhengze Lu, Yang Long, Zhirong Zhang & Qin He. (2020) Autophagy inhibition changes the disposition of non-viral gene carriers during blood-brain barrier penetration and enhances TRAIL-induced apoptosis in brain metastatic tumor. Journal of Controlled Release 321, pages 497-508.
Crossref
Crossref
Zhaowei Sun, Lei Wang, Shuai Wu, Yanhong Pan, Yu Dong, Sha Zhu, Jie Yang, Yongmei Yin & Genxi Li. (2020) An Electrochemical Biosensor Designed by Using Zr-Based Metal–Organic Frameworks for the Detection of Glioblastoma-Derived Exosomes with Practical Application. Analytical Chemistry 92:5, pages 3819-3826.
Crossref
Crossref
Nicolas AsquierGuillaume BouchouxMichael CanneyCyril MartinBruno Law-YeDelphine LeclercqJean-Yves ChapelonCyril LafonAhmed IdbaihAlexandre Carpentier. (2020) Blood-brain barrier disruption in humans using an implantable ultrasound device: quantification with MR images and correlation with local acoustic pressure. Journal of Neurosurgery 132:3, pages 875-883.
Crossref
Crossref
Weijun WangSteve SwensonHee-Yeon ChoFlorence M. Hofman, Axel H. Schönthal & Thomas C. Chen. (2020) Efficient brain targeting and therapeutic intracranial activity of bortezomib through intranasal co-delivery with NEO100 in rodent glioblastoma models. Journal of Neurosurgery 132:3, pages 959-967.
Crossref
Crossref
Irina Lyakhova, Mariia Piatkova, Valeriia Gulaia, Aleksandr Romanishin, Mikhail Shmelev, Andrey Bryukhovetskiy, Aruna Sharma, Hari Shanker Sharma, Rodion Khotimchenko & Igor Bryukhovetskiy. 2020. Novel Therapeutic Advances in Glioblastoma. Novel Therapeutic Advances in Glioblastoma
299
324
.
Igor Bryukhovetskiy, Oleg Pak, Yuri Khotimchenko, Andrey Bryukhovetskiy, Aruna Sharma & Hari Shanker Sharma. 2020. Novel Therapeutic Advances in Glioblastoma. Novel Therapeutic Advances in Glioblastoma
67
98
.
Sheng-Kai Wu, Chia-Lin Tsai & Kullervo Hynynen. 2022. Physiology, Pharmacology and Pathology of the Blood-Brain Barrier. Physiology, Pharmacology and Pathology of the Blood-Brain Barrier
351
364
.
Eurydice Angeli, Thuy T. Nguyen, Anne Janin & Guilhem Bousquet. (2019) How to Make Anticancer Drugs Cross the Blood–Brain Barrier to Treat Brain Metastases. International Journal of Molecular Sciences 21:1, pages 22.
Crossref
Crossref
Antonin Dréan, Nolwenn Lemaire, Guillaume Bouchoux, Lauriane Goldwirt, Michael Canney, Larissa Goli, Amira Bouzidi, Charlotte Schmitt, Jeremy Guehennec, Maïté Verreault, Marc Sanson, Jean-Yves Delattre, Karima Mokhtari, Frédéric Sottilini, Alexandre Carpentier & Ahmed Idbaih. (2019) Temporary blood–brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma. Journal of Neuro-Oncology 144:1, pages 33-41.
Crossref
Crossref
Victoria M. Wu, Eric Huynh, Sean Tang & Vuk Uskoković. (2019) Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles). Acta Biomaterialia 88, pages 422-447.
Crossref
Crossref
Yu-Long Lan, Xun Wang, Yu-Jie Zou, Jin-Shan Xing, Jia-Cheng Lou, Shuang Zou, Bin-Bin Ma, Yan Ding & Bo Zhang. (2019) Bazedoxifene protects cerebral autoregulation after traumatic brain injury and attenuates impairments in blood–brain barrier damage: involvement of anti-inflammatory pathways by blocking MAPK signaling. Inflammation Research 68:4, pages 311-323.
Crossref
Crossref
Jin‐Shan Xing, Xun Wang, Yu‐Long Lan, Jia‐Cheng Lou, Binbin Ma, Tingzhun Zhu, Hongqiang Zhang, Dongsheng Wang, Zhikuan Yu, Zhongbo Yuan, Xin‐Yu Li & Bo Zhang. (2019) Isoalantolactone inhibits IKKβ kinase activity to interrupt the NF‐κB/COX‐2‐mediated signaling cascade and induces apoptosis regulated by the mitochondrial translocation of cofilin in glioblastoma. Cancer Medicine 8:4, pages 1655-1670.
Crossref
Crossref
Eleanor C. FiedlerMichael T. Hemann. (2019) Aiding and Abetting: How the Tumor Microenvironment Protects Cancer from Chemotherapy. Annual Review of Cancer Biology 3:1, pages 409-428.
Crossref
Crossref
Kiran Rawat, Amit Shard, Manali Jadhav, Mayuri Gandhi, Prince Anand, Rituraj Purohit, Yogendra Padwad & Arun K. Sinha. (2019) Styryl-cinnamate hybrid inhibits glioma by alleviating translation, bioenergetics and other key cellular responses leading to apoptosis. Experimental Cell Research 375:1, pages 11-21.
Crossref
Crossref
Guilherme Felipe dos Santos Fernandes, Barbara Colatto Fernandes, Valeria Valente & Jean Leandro dos Santos. (2019) Recent advances in the discovery of small molecules targeting glioblastoma. European Journal of Medicinal Chemistry 164, pages 8-26.
Crossref
Crossref
Liron L. Israel, Oliver Braubach, Anna Galstyan, Antonella Chiechi, Ekaterina S. Shatalova, Zachary Grodzinski, Hui Ding, Keith L. Black, Julia Y. Ljubimova & Eggehard Holler. (2019) A Combination of Tri-Leucine and Angiopep-2 Drives a Polyanionic Polymalic Acid Nanodrug Platform Across the Blood–Brain Barrier. ACS Nano.
Crossref
Crossref
Swadesh K. Das, Devanand Sarkar, Luni Emdad & Paul B. Fisher. 2019.
137
191
.
Megha Gautam, Sahil Srivastav, Niharika Tiwary, Shweta Dang & Reema Gabrani. 2019. Natural Bio-active Compounds. Natural Bio-active Compounds
201
213
.
Mandy van Gulijk, Floris Dammeijer, Joachim G. J. V. Aerts & Heleen Vroman. (2018) Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy. Frontiers in Immunology 9.
Crossref
Crossref
Sébastien Goutal, Matthieu Gerstenmayer, Sylvain Auvity, Fabien Caillé, Sébastien Mériaux, Irène Buvat, Benoit Larrat & Nicolas Tournier. (2018) Physical blood-brain barrier disruption induced by focused ultrasound does not overcome the transporter-mediated efflux of erlotinib. Journal of Controlled Release 292, pages 210-220.
Crossref
Crossref
Antonin Dréan, Shai Rosenberg, François-Xavier Lejeune, Larissa Goli, Aravindan Arun Nadaradjane, Jérémy Guehennec, Charlotte Schmitt, Maïté Verreault, Franck Bielle, Karima Mokhtari, Marc Sanson, Alexandre Carpentier, Jean-Yves Delattre & Ahmed Idbaih. (2018) ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma. Journal of Neuro-Oncology 138:3, pages 479-486.
Crossref
Crossref
Xun Wang, Zhenlong Yu, Chao Wang, Wei Cheng, Xiangge Tian, Xiaokui Huo, Yan Wang, Chengpeng Sun, Lei Feng, Jinshan Xing, Yulong Lan, Dongdong Sun, Qingjuan Hou, Baojing Zhang, Xiaochi Ma & Bo Zhang. (2017) Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades. Journal of Experimental & Clinical Cancer Research 36:1.
Crossref
Crossref
M. Touat, A. Idbaih, M. Sanson & K.L. Ligon. (2017) Glioblastoma targeted therapy: updated approaches from recent biological insights. Annals of Oncology 28:7, pages 1457-1472.
Crossref
Crossref
Thangirala Sudha, Dhruba J. Bharali, Stewart Sell, Noureldien H. E. Darwish, Paul J. Davis & Shaker A. Mousa. (2017) Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts. Hormones and Cancer 8:3, pages 157-165.
Crossref
Crossref
Mehrdad Khoshnevis, Claude Carozzo, Catherine Bonnefont-Rebeix, Sara Belluco, Olivia Leveneur, Thomas Chuzel, Elodie Pillet-Michelland, Matthieu Dreyfus, Thierry Roger, François Berger & Frédérique Ponce. (2017) Development of induced glioblastoma by implantation of a human xenograft in Yucatan minipig as a large animal model. Journal of Neuroscience Methods 282, pages 61-68.
Crossref
Crossref
Julia Y. Ljubimova, Tao Sun, Leila Mashouf, Alexander V. Ljubimov, Liron L. Israel, Vladimir A. Ljubimov, Vida Falahatian & Eggehard Holler. (2017) Covalent nano delivery systems for selective imaging and treatment of brain tumors. Advanced Drug Delivery Reviews 113, pages 177-200.
Crossref
Crossref